Wall Street analyst estimates for Sanara MedTech Inc. (SMTI): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and post-acute care facilities.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-11 | $0.06 | ||
| 2026-08-11 | $-0.05 | $-0.03 | -100.0% |
| 2026-05-11 | $0.04 | $-0.04 | +200.0% |
| 2026-03-24 | $0.04 | $0.11 | -63.6% |
| 2025-11-12 | $0.09 | $-0.24 | +137.5% |
| 2025-08-13 | $-0.23 | $-0.33 | +30.3% |
| 2025-05-14 | $-0.41 | $-0.31 | -32.3% |
| 2025-03-25 | $-0.18 | $-0.19 | +5.3% |
Valuation Ratios
| Price / Book | 38.64 |
| EV / EBITDA | 37.56 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.5M | $6.3M | $5.8M | $11.8M | $15.6M | $24.1M | $45.8M | $65.0M | $86.7M | $103.1M |
| Cost of Revenue | $943579 | $806038 | $507418 | $1.2M | $1.6M | $2.3M | $6.4M | $7.9M | $8.1M | $10.2M |
| Gross Profit | $4.6M | $5.5M | $5.3M | $10.6M | $14.0M | $21.8M | $39.5M | $57.1M | $78.5M | $92.9M |
| Research & Development | 0 | 0 | 0 | 0 | $40190 | $558704 | $3.4M | $4.1M | $5.7M | $5.1M |
| Selling, General & Admin | $4.8M | $5.3M | $5.7M | $13.1M | $18.7M | $28.1M | $46.0M | $57.0M | $76.6M | $78.7M |
| Operating Expenses | $4.8M | $5.4M | $5.8M | $13.3M | $19.0M | $29.2M | $52.0M | $61.4M | $85.2M | $83.8M |
| Operating Income | -$272133 | $120444 | -$501860 | -$2.7M | -$5.0M | -$7.4M | -$12.5M | -$4.2M | -$6.7M | $9.1M |
| EBITDA | -$180372 | $538777 | -$417970 | -$2.6M | -$4.1M | -$7.2M | -$11.6M | -$289097 | -$1.9M | $9.0M |
| Interest Expense | $174493 | $126825 | $86587 | $105919 | $11528 | $711 | $284746 | $475783 | $3.1M | $6.8M |
| Pre-tax Income | -$415747 | $331309 | -$600574 | -$2.8M | -$4.4M | -$8.0M | -$13.9M | -$4.4M | -$9.9M | -$393124 |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | -$5.8M | 0 | 0 | 0 |
| Net Income | -$415747 | $331309 | -$600574 | -$2.8M | -$4.4M | -$7.9M | -$7.9M | -$4.3M | -$9.7M | -$37.6M |
| EPS | $-0.38 | $0.17 | $-0.28 | $-1.37 | $-0.76 | $-1.08 | $-1.00 | $-0.52 | $-1.14 | $-4.36 |
| EPS (Diluted) | $-0.38 | $0.09 | $-0.28 | $-1.37 | $-0.76 | $-1.08 | $-1.00 | $-0.52 | $-1.14 | $-4.36 |
| Shares Outstanding (Diluted) | $1.1M | $2.1M | $2.2M | $2.1M | $5.7M | $7.3M | $7.9M | $8.3M | $8.5M | $8.6M |
Price
| Price | $35.10 |
| Market Cap | $323M |
| Exchange | NASDAQ |
| Country | US |
Related companies: HITI · LFMD · NEO · OMI · SGHT · STXS · TBRG
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of SMTI: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks